RU 486 (A) Harvard Case Solution & Analysis

Describes the factors faced by Roussel UCLAF, a French pharmaceutical company, in deciding whether and how to sell a controversial new drug, RU 486, which is often called the "French abortion pill." Decision Roussel part in its relations with the French government, its parent company, the German chemical giant Hoechst, supporters and opponents of abortion rights in France and the U.S., and the scientific community. The goal is to show students face a complex web of responsibilities of managers and the practical issues that arise conflicts between these obligations. "Hide
by Joseph L. Badaracco Jr., Christopher Sturr Source: Harvard Business School 12 pages. Publication Date: 02 Oct 1990. Prod. #: 391050-PDF-ENG

Share This

SALE SALE

Save Up To

30%

IN ONLINE CASE STUDY

FOR FREE CASES AND PROJECTS INCLUDING EXCITING DEALS PLEASE REGISTER YOURSELF !!

Register now and save up to 30%.